Docgo Inc Stock EBITDA
| DCGO Stock | USD 4.25 0.13 3.16% |
DocGo Inc fundamentals help investors to digest information that contributes to DocGo's financial success or failures. It also enables traders to predict the movement of DocGo Stock. The fundamental analysis module provides a way to measure DocGo's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DocGo stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 32.7 M | 34.4 M |
DocGo | EBITDA |
DocGo Inc Company EBITDA Analysis
DocGo's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current DocGo EBITDA | 32.73 M |
Most of DocGo's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DocGo Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
DocGo EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for DocGo is extremely important. It helps to project a fair market value of DocGo Stock properly, considering its historical fundamentals such as EBITDA. Since DocGo's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DocGo's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DocGo's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
DocGo Ebitda
Ebitda |
|
According to the company disclosure, DocGo Inc reported earnings before interest,tax, depreciation and amortization of 32.73 M. This is 96.27% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 99.16% higher than that of the company.
DocGo EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DocGo's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DocGo could also be used in its relative valuation, which is a method of valuing DocGo by comparing valuation metrics of similar companies.DocGo is currently under evaluation in ebitda category among its peers.
DocGo ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, DocGo's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to DocGo's managers, analysts, and investors.Environmental | Governance | Social |
DocGo Institutional Holders
Institutional Holdings refers to the ownership stake in DocGo that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of DocGo's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing DocGo's value.| Shares | Millennium Management Llc | 2024-06-30 | 1.1 M | Franklin Resources Inc | 2024-06-30 | 1.1 M | 1492 Capital Management, Llc | 2024-09-30 | 853.3 K | Charles Schwab Investment Management Inc | 2024-09-30 | 770.2 K | Kennedy Capital Management Inc | 2024-06-30 | 712.8 K | Isthmus Partners Llc | 2024-09-30 | 638 K | Marshall Wace Asset Management Ltd | 2024-06-30 | 505.5 K | D. E. Shaw & Co Lp | 2024-06-30 | 505.4 K | Birchview Capital, Lp | 2024-06-30 | 460 K | Deerfield Management Co | 2024-06-30 | 7.2 M | Blackrock Inc | 2024-06-30 | 7 M |
DocGo Fundamentals
| Return On Equity | 0.0941 | ||||
| Return On Asset | 0.0658 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 401.24 M | ||||
| Shares Outstanding | 102.05 M | ||||
| Shares Owned By Insiders | 9.91 % | ||||
| Shares Owned By Institutions | 54.94 % | ||||
| Number Of Shares Shorted | 7.13 M | ||||
| Price To Earning | 17.46 X | ||||
| Price To Book | 1.33 X | ||||
| Price To Sales | 0.62 X | ||||
| Revenue | 624.29 M | ||||
| Gross Profit | 154.72 M | ||||
| EBITDA | 32.73 M | ||||
| Net Income | 10.05 M | ||||
| Cash And Equivalents | 198.14 M | ||||
| Cash Per Share | 1.96 X | ||||
| Total Debt | 46.5 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 4.76 X | ||||
| Book Value Per Share | 3.19 X | ||||
| Cash Flow From Operations | (64.22 M) | ||||
| Short Ratio | 17.95 X | ||||
| Earnings Per Share | 0.29 X | ||||
| Price To Earnings To Growth | 1.05 X | ||||
| Target Price | 22.83 | ||||
| Number Of Employees | 2.92 K | ||||
| Beta | 0.89 | ||||
| Market Capitalization | 433.72 M | ||||
| Total Asset | 490.45 M | ||||
| Retained Earnings | (21.39 M) | ||||
| Working Capital | 168.75 M | ||||
| Net Asset | 490.45 M |
About DocGo Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DocGo Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DocGo using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DocGo Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with DocGo
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DocGo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DocGo will appreciate offsetting losses from the drop in the long position's value.Moving together with DocGo Stock
Moving against DocGo Stock
| 0.8 | FIGS | Figs Inc | PairCorr |
| 0.77 | PHG | Koninklijke Philips | PairCorr |
| 0.64 | CVS | CVS Health Corp Aggressive Push | PairCorr |
| 0.64 | EVH | Evolent Health | PairCorr |
| 0.52 | AGL | agilon health | PairCorr |
The ability to find closely correlated positions to DocGo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DocGo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DocGo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DocGo Inc to buy it.
The correlation of DocGo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DocGo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DocGo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DocGo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out DocGo Piotroski F Score and DocGo Altman Z Score analysis. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DocGo. If investors know DocGo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DocGo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.09 | Earnings Share 0.29 | Revenue Per Share 6.752 | Quarterly Revenue Growth (0.26) | Return On Assets 0.0658 |
The market value of DocGo Inc is measured differently than its book value, which is the value of DocGo that is recorded on the company's balance sheet. Investors also form their own opinion of DocGo's value that differs from its market value or its book value, called intrinsic value, which is DocGo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DocGo's market value can be influenced by many factors that don't directly affect DocGo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DocGo's value and its price as these two are different measures arrived at by different means. Investors typically determine if DocGo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DocGo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.